RxDoctor Payments Data

Jengyu Lai, DPM

Podiatrist · Rochester, MNNPI 1750383808

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (42.7%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Reprise Biomedical, Inc. at 43.2% of the total. Reporting peaked in 2024 at $4,118 and has fallen 91.4% since, to $353 in 2025.

$4,950in general payments, 2019–2025

Across 32 payments — averaging $154.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Reprise Biomedical, Inc.$2K
  • Merakris Therapeutics, Inc.$2K
  • Kerecis Limited$444
  • Abbott$130
  • Next Science LLC$129
  • Reddress USA, Inc.$106
  • plus $503 from 11 others

What the payments were for

  • Speaking & faculty fees$1,50030%
  • Travel & lodging$2,11643%
  • Food & beverage$1,20624%
  • Education$1293%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,950 in reported general payments places this provider in the 80th percentile of 105 podiatrist providers in Minnesota.

See all podiatrist providers in Minnesota

Medicare billing

Part B allowed, 2024
$1,867,495
Medicare patients
117
Services billed
1,740

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other podiatrist in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →